A Hugli
Overview
Explore the profile of A Hugli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allal A, Ares C, Dulguerov P, Tschanz E, Verdan C, Mhawech P, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:89-108.
PMID: 27137923
No abstract available.
2.
Taban F, Rapiti E, Fioretta G, Wespi Y, Weintraub D, Hugli A, et al.
Ann Oncol
. 2012 Sep;
24(1):116-25.
PMID: 22945380
Background: Studies have reported that breast cancer (BC) units could increase the quality of care but none has evaluated the efficacy of alternative options such as private BC networks, which...
3.
VECCHIETTI G, Kerl K, Hugli A, Samson J, Borradori L
Br J Dermatol
. 2003 May;
148(4):833-4.
PMID: 12752158
No abstract available.
4.
Borradori L, Lombardi T, Samson J, Girardet C, Saurat J, Hugli A
Arch Dermatol
. 2001 Mar;
137(3):269-72.
PMID: 11255323
No abstract available.
5.
Hugli A, Sappino A, Anchisi S, Mermillod B, Schafer P, Anguenot J, et al.
Ann Oncol
. 2001 Feb;
11(12):1557-61.
PMID: 11205463
We performed a trial using the combination of epirubicin 50 mg/m2/day 1, carboplatinum AUC 5/day 1 and continuous 5-fluorouracil (5-FU) 200 mg/m2/day (every 4 weeks for 6 months) to confirm...
6.
Hugli A, Moro D, Mermillod B, Bolla M, Alberto P, Bonnefoi H, et al.
J Clin Oncol
. 2000 Apr;
18(8):1662-7.
PMID: 10764426
Purpose: To investigate the feasibility and outcome of bifractionated, up-front thoracic radiotherapy (TR) (45 Gy in 30 fractions of 1.5 Gy twice daily over 3 weeks) combined with chemotherapy (CT)...
7.
Villard J, Roux-Lombard P, Hugli A, Dayer J
Crit Care Med
. 1993 Sep;
21(9):1396-400.
PMID: 8396525
No abstract available.
8.
Beris P, Mermillod B, Levy G, Laubriat M, Tullen E, Hugli A, et al.
Vox Sang
. 1993 Jan;
65(3):212-8.
PMID: 8249364
In a prospective randomized study we investigated the potential of subcutaneous recombinant human erythropoietin (rhEpo) as adjuvant treatment for autologous blood transfusions (3 units) in elective surgery. Four and 2...
9.
Hugli A, Beris P
Nouv Rev Fr Hematol (1978)
. 1989 Jan;
31(3):223-30.
PMID: 2694095
Between 1981 and 1988, we recorded 11 patients presenting a neoplastic microangiopathy. All patients suffered from adenocarcinoma, except one with an undifferentiated lung carcinoma; the origin of the tumor was...